4th Quarter - Report

POLSINELLI PC for LEUKEMIA & LYMPHOMA SOCIETY

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues pertaining to quality of care for blood cancers [Patients Access to Treatment Act, H.R. 460 - all provisions; Cancer Drug Coverage Parity Act, H.R. 1801 - all provisions; Kids First Research Act, H.R. 2019 - all provisions; Medicare exceptions process within prescription drug plans, H.R. 2827 - all provisions]

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE

Bills named: H.R. 2827 (113th), H.R. 2019 (113th), H.R. 1801 (113th), H.R. 460 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.